Life Sciences Review

About Us

Conference

Partner With Us

Proteomics

Worldwide Patients Access to Life-Changing Therapies

Kinga Bercsenyi

PhD, European Lead for Precision Medicine & Biomarker Solutions

Cerba Research

Science-Led Data Collection: Because a Clinical Trial is Only as Good as Its Data

Lindsay Hughes

PhD, MS – Director, eCOA Science & Consulting and Jowita Marszewska, PhD – eCOA Scientific Advisor

Clario

Featured Issue

Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Roman Mathaes, Head of Pharmaceutical Services and Cristina GrigoreCristina Grigore Lonza

Cloud Computing Driving Change in Pharma Industry

Chris Braithwaite, SVP and Global Head of Drug Development Digital and IT Novartis

How Regulatory has Become Strategically Important to Food and Feed Companies

Caroline Herody, Head of Global Regulatory Affairs Chr. Hansen

COVID-19 as a Catalyst for Digital Transformation of Clinical Research: Are we there yet?

Dr. Ammar Raza, Regional Medical Director- Middle East and Africa, Allergan Aesthetics, an AbbVie company, Dubai

Beyond Industry 4.0: The Pharma Supply Chain of the Future

Mirko Senatore, Senior Director Global Supply Chain, Eastern Europe and Central Asia

Pfizer

Proteomics in Health Sciences

Philippe Pinton, Senior Vice President, Head, Global Research and Medical

Ferring Pharmaceuticals

Biodesix, Inc. (NASDAQ: BDSX): The Market Leader In The Clinical Proteomics Field

Gary Pestano, Ph.D., Chief Development Officer and Robert W. Georgantas III, Ph.D., Chief Scientific Officer & Kieran O'Kane, Chief Commercial Officer

Specials

Proteomics

Worldwide Patients Access to Life-Changing Therapies

Science-Led Data Collection: Because a Clinical Trial is Only as Good as Its Data

Featured Issue

Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Cloud Computing Driving Change in Pharma Industry

How Regulatory has Become Strategically Important to Food and Feed Companies

COVID-19 as a Catalyst for Digital Transformation of Clinical Research: Are we there yet?

Beyond Industry 4.0: The Pharma Supply Chain of the Future

Proteomics in Health Sciences

Biodesix, Inc. (NASDAQ: BDSX): The Market Leader In The Clinical Proteomics Field

News

Clinical Trial Management Moves Toward A More Connected Model

Biomarker Claims Face Evidence Test

Choosing an ADC and AOC CDMO Partner for Complex Bioconjugates

Biomarker Results Leave Decisions Open